Are rates of pediatric bipolar disorder increasing? Results from a nationwide register study

Lars Vedel Kessing1, Eleni Vradi2, Per Kragh Andersen2

  • 1Psychiatric Center Copenhagen, Department O, 6233 and University of Copenhagen, Blegdamsvej 9, Copenhagen, 2100 Denmark.

Insights

Pediatric bipolar disorder rates doubled in Denmark from 1995-2012. This increase appears to reflect a true rise in illness, not just increased diagnostic attention, as age at diagnosis and timing remained consistent.

Area of Science:

  • Child and Adolescent Psychiatry
  • Epidemiology
  • Mental Health Research

Background:

  • US studies indicate rising pediatric bipolar disorder rates since the mid-1990s.
  • No international studies outside the US have examined pediatric bipolar disorder incidence.
  • It remains unclear if rising rates reflect true incidence or increased diagnostic focus.

Purpose of the Study:

  • Investigate gender-specific rates of pediatric mania/bipolar disorder in Denmark (1995-2012).
  • Examine changes in age and characteristics of pediatric bipolar disorder diagnoses over time.
  • Determine if diagnoses are made earlier in the course of psychiatric contact in recent years.

Main Methods:

  • Utilized nationwide Danish registers of all inpatient and outpatient psychiatric contacts (1995-2012).
  • Analyzed 346 patients with a primary diagnosis of manic episode (F30) or bipolar affective disorder (F31).
  • Compared diagnostic characteristics between two periods: 1995-2003 and 2004-2012.

Main Results:

  • Annual rates of pediatric mania/bipolar disorder doubled to quadrupled for both sexes during the study period.
  • Median age at diagnosis remained consistent (around 17 years) across both periods.
  • No significant changes were observed in the timing of diagnosis relative to first psychiatric contact.

Conclusions:

  • The incidence of pediatric mania/bipolar disorder significantly increased in Denmark between 1995 and 2012.
  • This rise is unlikely attributable to increased diagnostic attention alone.
  • Findings suggest a genuine increase in the prevalence of pediatric bipolar disorder.

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.4K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
788
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
394
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
2.0K
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
1.5K